BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31329999)

  • 1. DEVELOPMENT OF CALCULATION TOOL FOR RESPIRATORY TRACT DEPOSITION DEPENDING ON AEROSOLS PARTICLE DISTRIBUTION.
    Iwaoka K; Hosoda M; Tokonami S; Enriquez EB; Palad LJH; Kanda R
    Radiat Prot Dosimetry; 2019 Oct; 184(3-4):388-390. PubMed ID: 31329999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation Dosimetry of Inhaled Radioactive Aerosols: CFPD and MCNP Transport Simulations of Radionuclides in the Lung.
    Talaat K; Xi J; Baldez P; Hecht A
    Sci Rep; 2019 Nov; 9(1):17450. PubMed ID: 31768010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: particle clearance.
    Bolch WE; Huston TE; Farfán EB; Vernetson WG; Bolch WE
    Health Phys; 2003 Apr; 84(4):421-35. PubMed ID: 12705441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation of deposition and clearance of inhaled particles in central human airways.
    Balásházy I; Farkas A; Szöke I; Hofmann W; Sturm R
    Radiat Prot Dosimetry; 2003; 105(1-4):129-32. PubMed ID: 14526942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical application of the ICRP Human Respiratory Tract Model.
    Bailey MR; Ansoborlo E; Guilmette RA; Paquet F
    Radiat Prot Dosimetry; 2003; 105(1-4):71-6. PubMed ID: 14526930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: regional tissue doses for 239PuO2 and 238UO2/238U3O8.
    Farfán EB; Huston TE; Bolch WE; Vernetson WG; Bolch WE
    Health Phys; 2003 Apr; 84(4):436-50. PubMed ID: 12705442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stochastic model of ultrafine particle deposition and clearance in the human respiratory tract.
    Hofmann W; Sturm R; Winkler-Heil R; Pawlak E
    Radiat Prot Dosimetry; 2003; 105(1-4):77-80. PubMed ID: 14526931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the importance of the particle size effect in inhalation dose assessment for short-term radiological events.
    Srimok B; Yim MS
    Radiat Prot Dosimetry; 2011 Nov; 147(3):439-50. PubMed ID: 21156784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Aerosol Density and Shape Factor on the Assessment of Internal Exposure to 239Pu.
    Zhang B; Sheng W; Xu M; Zhang Y; Lei JY; Ma HC
    Health Phys; 2019 Oct; 117(4):353-361. PubMed ID: 31453880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dust particle size effects on absorbed fraction values in the anterior nose.
    Moussa HM
    Health Phys; 2007 Oct; 93(4):307-11. PubMed ID: 17846527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values.
    Oller AR; Oberdörster G
    Regul Toxicol Pharmacol; 2010; 57(2-3):181-94. PubMed ID: 20172011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle deposition in a child respiratory tract model: in vivo regional deposition of fine and ultrafine aerosols in baboons.
    Albuquerque-Silva I; Vecellio L; Durand M; Avet J; Le Pennec D; de Monte M; Montharu J; Diot P; Cottier M; Dubois F; Pourchez J
    PLoS One; 2014; 9(4):e95456. PubMed ID: 24787744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDEP: A Resource for Calculating Particle Deposition in the Respiratory Tract.
    Klumpp J; Bertelli L
    Health Phys; 2017 Aug; 113(2):110-121. PubMed ID: 28658056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AEROSOL SIZE DISTRIBUTION IN URANIUM PROCESSING FACILITY FOR APPLICATION IN THE ASSESSMENT OF INTERNAL EXPOSURE.
    Shailesh M; Das T; Prabhat M; Kolekar RV; Gopalakrishnan RK
    Radiat Prot Dosimetry; 2018 Apr; 179(2):119-124. PubMed ID: 29088460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the basic characteristics of aerosols suitable for studies of deposition in the respiratory tract.
    Legáth L; Naus A; Halík J
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(3):287-97. PubMed ID: 3198910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective dose scaling factors for use with cascade impactor sampling data in tenorm inhalation exposures.
    Kim KP; Wu CY; Birky BK; Bolch WE
    Health Phys; 2005 Oct; 89(4):359-74. PubMed ID: 16155458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Deposition of particles in the respiratory tract].
    Lieutier-Colas F
    Allerg Immunol (Paris); 2001 Feb; 33(2):59-63. PubMed ID: 11339054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of calculation tool for iodine 131 biodistribution depending on the aerosol particle distribution.
    Iwaoka K; Enriquez EB; Tamakuma Y; Hosoda M; Tokonami S; Feliciano CP; Kanda R
    Radiat Prot Dosimetry; 2023 Nov; 199(18):2244-2247. PubMed ID: 37934980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle deposition in human respiratory system: deposition of concentrated hygroscopic aerosols.
    Varghese SK; Gangamma S
    Inhal Toxicol; 2009 Jun; 21(7):619-30. PubMed ID: 19459776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of airborne particles from cleaning sprays and their corresponding respiratory deposition fractions.
    Lovén K; Isaxon C; Wierzbicka A; Gudmundsson A
    J Occup Environ Hyg; 2019 Sep; 16(9):656-667. PubMed ID: 31361572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.